MedicationAgreement-v1.0.1(2017EN): verschil tussen versies

Uit Zorginformatiebouwstenen
Naar navigatie springen Naar zoeken springen
(Copy of)
Geen bewerkingssamenvatting
Regel 1: Regel 1:
==General information==
<!-- Hieronder wordt een transclude page aangeroepen -->
Name: '''nl.zorg.MedicationAgreement''' [[Bestand:NL.png|link=Medicatieafspraak-v1.0.1(2017NL)]]<BR>
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.6(EN)|1|MedicationAgreement-v1.0.1(2017EN)}}
Version: '''1.0.1''' <br>
<!-- Tot hier de transclude page -->
HCIM Status:Final<br>
==General information<!--hdGeneralInformation-->==
Release: '''2017''' <br>
Name<!--hdName-->: '''nl.zorg.MedicationAgreement''' [[Bestand:NL.png|link=Medicatieafspraak-v1.0.1(2017NL)]]<BR>
Release status: Published<br>
Version<!--hdVersion-->: '''1.0.1''' <br>
Release date: 31-12-2017
HCIM Status<!--hdStatus-->:Final<br>
Release<!--hdPublication-->: '''2017''' <br>
Release status<!--hdPublicationStatus-->: Published<br>
Release date<!--hdPublicationDate-->: 31-12-2017
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2017(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2017(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>


==Metadata==
==Metadata==
Regel 61: Regel 64:
==Revision History==
==Revision History==
<div class="mw-collapsible mw-collapsed">
<div class="mw-collapsible mw-collapsed">
''Only available in Dutch''
''Only available in Dutch<!--noTranslation-->''


<u>Publicatieversie 1.0</u> (04-09-2017)
<u>Publicatieversie 1.0</u> (04-09-2017)
Regel 85: Regel 88:
<BR>
<BR>
<imagemap> Bestand:MedicationAgreement-v1.0.1Model(EN).png | center  
<imagemap> Bestand:MedicationAgreement-v1.0.1Model(EN).png | center  
rect 283 540 557 590 [[#MedicationAgreementAdditionalInformationCodeList]]
rect 293 548 567 598 [[#MedicationAgreementAdditionalInformationCodeList]]
rect 352 445 562 515 [[#13304]]
rect 362 453 572 523 [[#13304]]
rect 170 69 312 139 [[Problem-v4.1(2017EN)]]
rect 180 77 322 147 [[Problem-v4.1(2017EN)]]
rect 775 196 917 263 [[PharmaceuticalProduct-v2.0(2017EN)]]
rect 785 204 927 271 [[PharmaceuticalProduct-v2.0(2017EN)]]
rect 771 541 981 590 [[#MedicationAgreementStopTypeCodeList]]
rect 781 549 991 598 [[#MedicationAgreementStopTypeCodeList]]
rect 567 540 761 590 [[#MedicationAgreementReasonCodeList]]
rect 577 548 771 598 [[#MedicationAgreementReasonCodeList]]
rect 333 68 453 135 [[HealthProfessional-v3.2(2017EN)]]
rect 343 76 463 143 [[HealthProfessional-v3.2(2017EN)]]
rect 474 69 594 136 [[BodyWeight-v3.1(2017EN)]]
rect 484 77 604 144 [[BodyWeight-v3.1(2017EN)]]
rect 615 69 757 136 [[BodyHeight-v3.1(2017EN)]]
rect 625 77 767 144 [[BodyHeight-v3.1(2017EN)]]
rect 777 320 919 387 [[#13318]]
rect 787 328 929 395 [[#13318]]
rect 597 445 739 515 [[#13305]]
rect 607 453 749 523 [[#13305]]
rect 774 444 916 511 [[#13314]]
rect 784 452 926 519 [[#13314]]
rect 174 319 322 389 [[#13306]]
rect 184 327 332 397 [[#13306]]
rect 169 445 317 515 [[TimeInterval-v1.0(2017EN)]]
rect 179 453 327 523 [[TimeInterval-v1.0(2017EN)]]
rect 776 72 918 139 [[InstructionsForUse-v1.1(2017EN)]]
rect 786 80 928 147 [[InstructionsForUse-v1.1(2017EN)]]
rect 170 195 318 263 [[#13312]]
rect 180 203 328 271 [[#13312]]
rect 468 253 606 320 [[#13317]]
rect 478 261 616 328 [[#13317]]
desc none
desc none
</imagemap>
</imagemap>
Regel 107: Regel 110:
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|style="width:30px;"|Type<!--imType-->||style="width:100px;"|Id<!--imId-->||colspan="6 " style="width:140px;"|Concept<!--imConcept-->||Card.<!--imCard-->||style="width: 600px;"|Definition<!--imDefinition-->||style="width:200px;"|DefinitionCode<!--imDefinitionCode-->||style="width:200px;"|Reference<!--imReference-->
|-style="vertical-align:top; background-color: #E3E3E3; "
|-style="vertical-align:top; background-color: #E3E3E3; "
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
Regel 288: Regel 291:
{|
{|
|-
|-
|<span Title="Codesystem: LOINC"> 48767-8 Annotation comment</span>
|<span title = "Codesystem: LOINC>[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Annotation comment</span>
|}
|}
|
|
|}
|}
Columns Concept and DefinitionCode: hover over the values for more information<BR>
Columns Concept and DefinitionCode: hover over the values for more information<!--imHover--><BR>
For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]]
For explanation of the symbols, please see the legend page<!--imLegend--> [[Bestand:list2.png|link=Legend<!--wikiLegend-->]]


==Example Instances==
==Example Instances==
''Only available in Dutch''
''Only available in Dutch<!--noTranslation-->''


{|class="wikitable" width="1202px" style= "font-size: 9.5pt;"
{|class="wikitable" width="1202px" style= "font-size: 9.5pt;"
Regel 388: Regel 391:
{| class="wikitable" width="60%"  
{| class="wikitable" width="60%"  
|-style='vertical-align:top; background-color: #E8D7BE;'
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.3
|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.3
|Binding<!--vsBindingTag-->:
|}
|}
{| class="wikitable"  width="60% "
{| class="wikitable"  width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptname<!--vsConceptName-->
|Conceptcode
|Conceptcode<!--vsConceptCode-->
|Codesystem name||Codesystem OID
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Description
|Description<!--vsDescription-->
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Bewust hoge dosering
|Bewust hoge dosering
Regel 439: Regel 443:
|Wijziging in GDS per rolwissel
|Wijziging in GDS per rolwissel
|}
|}
=== MedicationAgreementReasonCodeList===
=== MedicationAgreementReasonCodeList===
{| class="wikitable" width="60%"  
{| class="wikitable" width="60%"  
|-style='vertical-align:top; background-color: #E8D7BE;'
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2
|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2
|Binding<!--vsBindingTag-->:
|}
|}
{| class="wikitable"  width="60% "
{| class="wikitable"  width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptname<!--vsConceptName-->
|Conceptcode
|Conceptcode<!--vsConceptCode-->
|Codesystem name||Codesystem OID
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Description
|Description<!--vsDescription-->
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Medication commenced (finding)
|Medication commenced (finding)
|266709005
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=266709005 266709005]
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
Regel 459: Regel 463:
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Administration of drug or medicament contraindicated (situation)
|Administration of drug or medicament contraindicated (situation)
|438833006
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=438833006 438833006]
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
Regel 465: Regel 469:
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Drug interaction (disorder)
|Drug interaction (disorder)
|79899007
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=79899007 79899007]
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
Regel 471: Regel 475:
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Hypersensitivity condition (disorder)
|Hypersensitivity condition (disorder)
|473010000
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=473010000 473010000]
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
Regel 513: Regel 517:
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Admission to establishment (procedure)
|Admission to establishment (procedure)
|305335007
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=305335007 305335007]
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
Regel 548: Regel 552:
|Overig
|Overig
|}
|}
=== MedicationAgreementStopTypeCodeList===
=== MedicationAgreementStopTypeCodeList===
{| class="wikitable" width="60%"  
{| class="wikitable" width="60%"  
|-style='vertical-align:top; background-color: #E8D7BE;'
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.1
|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.1
|Binding<!--vsBindingTag-->:
|}
|}
{| class="wikitable"  width="60% "
{| class="wikitable"  width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptname<!--vsConceptName-->
|Conceptcode
|Conceptcode<!--vsConceptCode-->
|Codesystem name||Codesystem OID
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Description
|Description<!--vsDescription-->
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|Tijdelijk
|Tijdelijk
Regel 574: Regel 578:
|}
|}


 
==This information model in other releases<!--ftOtherReleases-->==
==This information model in other releases==
<!-- Hieronder wordt een transclude page aangeroepen -->
---
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.6(EN)|2|2017}}
==More on this information model==
<!-- Tot hier de transclude page -->
==Information model references<!--ftReferences-->==
====This information model refers to<!--ftRefersTo-->====
*[[BodyHeight-v3.1(2017EN)|BodyHeight-v3.1]]
*[[BodyWeight-v3.1(2017EN)|BodyWeight-v3.1]]
*[[HealthProfessional-v3.2(2017EN)|HealthProfessional-v3.2]]
*[[InstructionsForUse-v1.1(2017EN)|InstructionsForUse-v1.1]]
*[[PharmaceuticalProduct-v2.0(2017EN)|PharmaceuticalProduct-v2.0]]
*[[Problem-v4.1(2017EN)|Problem-v4.1]]
*[[TimeInterval-v1.0(2017EN)|TimeInterval-v1.0]]
====This information model is used in<!--ftReferredBy-->====
*[[AdministrationAgreement-v1.0.1(2017EN)|AdministrationAgreement-v1.0.1]]
*[[MedicationAdministration2-v1.0.1(2017EN)|MedicationAdministration2-v1.0.1]]
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->
<ul>
<ul>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.6&effectiveDate=2017-12-31T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment<!--ftArtDecorReference--> [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.6&effectiveDate=2017-12-31T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR [https://simplifier.net/NictizSTU3/~resources?text=zib&category=Profile [[File:fhir.png|link=]]]</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks|2017}}</li>
</ul>
</ul>
This information model is also available as [[Media:nl.zorg.MedicationAgreement-v1.0.1(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationAgreement-v1.0.1(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
==Downloads<!--ftDownloadTitle-->==
==About this information==
This information model is also available as [[Media:nl.zorg.MedicationAgreement-v1.0.1(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationAgreement-v1.0.1(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]<!--ftDownloads-->
The information in this wikipage is based on Release 2017 <BR>
==About this information<!--ftHeader2-->==
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
The information in this wikipage is based on<!--ftInfoBase--> Release 2017 <BR>
This page is generated on 24/01/2018 15:58:01 <BR>
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
This page is generated on 19/12/2018 18:32:32 with ZibExtraction v. 3.0.6927.32850<!--ftDate--> <BR>
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2017(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2017(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>

Versie van 20 dec 2018 13:31


Attention!! This is not the most recent version of this information model. You can find the most recent version ''here''.

General information

Name: nl.zorg.MedicationAgreement NL.png
Version: 1.0.1
HCIM Status:Final
Release: 2017
Release status: Published
Release date: 31-12-2017

Back 16.png Back to HCIM list

Metadata

DCM::CoderList Projectgroep Medicatieproces
DCM::ContactInformation.Address
DCM::ContactInformation.Name *
DCM::ContactInformation.Telecom
DCM::ContentAuthorList Projectgroep Medicatieproces
DCM::CreationDate 1-2-2017
DCM::DeprecatedDate
DCM::DescriptionLanguage nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name PM
DCM::EndorsingAuthority.Telecom
DCM::Id 2.16.840.1.113883.2.4.3.11.60.40.3.9.6
DCM::KeywordList Medicatie, Afspraak
DCM::LifecycleStatus Final
DCM::ModelerList Kerngroep Registratie aan de Bron
DCM::Name nl.zorg.Medicatieafspraak
DCM::PublicationDate 31-12-2017
DCM::PublicationStatus Published
DCM::ReviewerList Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron
DCM::RevisionDate 31-12-2017
DCM::Superseeds nl.zorg.Medicatieafspraak-v1.0
DCM::Version 1.0.1
HCIM::PublicationLanguage EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (04-09-2017)

Publicatieversie 1.0.1 (31-12-2017)

ZIB-618 Hernoemen Verstrekking naar Medicatieverstrekking
ZIB-643 Kleine tekstuele verbeteringen

Concept

A medication agreement is a prescriber’s proposal for a patient to use medication. An agreement to discontinue the use of medication is also a medication agreement.

Purpose

The goal of the medication agreement is to provide insight into the agreements reached between the prescriber and the patient on the use of medication.

Information Model


#MedicationAgreementAdditionalInformationCodeList#13304Problem-v4.1(2017EN)PharmaceuticalProduct-v2.0(2017EN)#MedicationAgreementStopTypeCodeList#MedicationAgreementReasonCodeListHealthProfessional-v3.2(2017EN)BodyWeight-v3.1(2017EN)BodyHeight-v3.1(2017EN)#13318#13305#13314#13306TimeInterval-v1.0(2017EN)InstructionsForUse-v1.1(2017EN)#13312#13317MedicationAgreement-v1.0.1Model(EN).png


Type Id Concept Card. Definition DefinitionCode Reference
Block.png NL-CM:9.6.9580 Arrowdown.pngMedicationAgreement Root concept of the MedicationAgreement information model. This root concept contains all data elements of the MedicationAgreement information model.
Verwijzing.png NL-CM:9.6.1030 Arrowright.pngPrescriber::HealthProfessional 0..1 The health professional that entered the medication agreement with the patient.
Block.png HealthProfessional
Verwijzing.png NL-CM:9.6.23133 Arrowright.pngPrescriptionReason::Problem 0..1 The medical reason for the prescription or for use of the medication. This can be used to enter a medical indication which was the direct cause for prescription or for use of the medication in question.

It can concern every type of problem (or condition) of the patient, almost all diagnoses, complaints or symptoms.

Please note: The BST401T file of the G standard contains a “special reference” to indicate that “exchange of the reason for prescription is essential”.

Block.png Problem
Verwijzing.png NL-CM:9.6.23028 Arrowright.pngBodyWeight 0..1 Weight the dose is based on, relevant to this agreement.
Block.png BodyWeight
Verwijzing.png NL-CM:9.6.23023 Arrowright.pngBodyHeight 0..1 Height the dose is based on, relevant to this agreement.
Block.png BodyHeight
Verwijzing.png NL-CM:9.6.19925 Arrowright.pngAgreedMedicine::FarmaceuticalProduct 1 The medicine agreed upon to be used.
Block.png PharmaceuticalProduct
Verwijzing.png NL-CM:9.6.23240 Arrowright.pngInstructionsForUse 0..1 Instructions for the use of the medication, e.g. dose and route of administration.
Block.png InstructionsForUse
TS.png NL-CM:9.6.19757 Arrowright.pngMedicationAgreementDateTime 1 The time at which the agreement was made.

Appointment date + time are required (order of the appointments must be clear in cases with multiple appointments on one day)

Verwijzing.png NL-CM:9.6.19936 Arrowright.pngPeriodOfUse 0..1 Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original medication agreement. The end date indicates from when the medication is to be discontinued.

Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days.

End date: The time at which the period of use ends (or ended or will end). In the case of an agreement to discontinue use, this is the time at which the medication is to be discontinued. To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date.

With medication for an indefinite period only a start date is indicated.

Block.png TimeInterval
BL.png NL-CM:9.6.23033 Arrowright.pngCanceledIndicator 0..1 In the event of an error correction of the medication agreement, this indicator is to be put on for the incorrect agreement.
CD.png NL-CM:9.6.19954 Arrowright.pngMedicationAgreementStopType 0..1 Stop type, the manner in which this medication is discontinued (temporary or definitive).
List2.png MedicationAgreementStopTypeCodeList
CD.png NL-CM:9.6.22094 Arrowright.pngReasonMedicationAgreement 0..1 Reason for this agreement. This can be the reason to start, change or stop the medication treatment.
List2.png MedicationAgreementReasonCodeList
CD.png NL-CM:9.6.23283 Arrowright.pngMedicationAgreementAdditionalInformation 0..* Additional information includes details on the structure of the agreement made that are relevant for pharmacovigilance and fulfillment by the pharmacist. This can be used e.g. to indicate that there was a conscious decision to deviate from the norm or that the agreement is to be structured in a certain way.

See also the Instructions section for more information about use of the element.

List2.png MedicationAgreementAdditionalInformationCodeList
ST.png NL-CM:9.6.22273 Arrowright.pngComment 0..1 Comments regarding to the medication agreement. For example: in consultation with the medical specialist.
48767-8 Annotation comment

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page List2.png

Example Instances

Only available in Dutch

MedicatieAfspraak DatumTijd Gebruiksperiode Afgesproken geneesmiddel Voorschrijver Geannuleerd Indicator MedicatieAfspraak Stoptype MedicatieAfspraak.Reden
Ingangsdatum Einddatum Duur FarmaceutischProduct Zorgverlener
Naamgegevens
18-9-2016 18:00:00 08-09-16 18-09-16 Lisinopril tablet 10mg D. Bakker Nee Definitief Geen of onvoldoende effect
6-3-2016 9:12:30 06-03-2016 Methotrexaat injvlst 25mg/ml 0,6 ml R. Jansen Nee Starten medicamenteuze behandeling
RedenVan Voorschrijven Gebruiksinstructie
Probleem Omschrijving Doseerinstructie
Doseerduur Dosering |Keerdosis Toedieningsschema |Frequentie |Interval |Toedientijd |Weekdag |Dagdeel
Van 8-9-2017 tot 18-9-2017 1x per dag 1 stuk. Vanaf 18-9-2017 staken. 1 stuk 1x per dag
Reumatoïde Artritis Vanaf 6 maart 2016 1x per week op maandag om 14uur 15 mg (=0,6 ml) 15 mg (=0,6 ml) 1x per week op maandag (14u)

Instructions

MedicationAgreementAdditionalInformation: When choosing a medicine, you can deviate from what is expected or from what the standard is. For example, when the hospital uses a different formulary than the community pharmacy. For reasons of efficiency, for example, one gastric acid inhibitor has been chosen in the hospital: pantoprazole.
Upon admission, a patient with omeprazole is converted to pantoprazole for the duration of the stay. When discharged, the patient goes back to omeprazole.
It is clear that something can go wrong here and that the patient takes both omeprazole and pantoprazole when there is no intervention. In the hospital's medication agreement for pantoprazole a remark can be made about the deviation so that it is clear that pantoprazole is the substitute for omeprazole or that it should be used in addition to omeprazole.
Another example are the half strengths. The hospital sometimes stocks tablets with half the strength of the normal trade preparation (own production). Where the patient enters the hospital on 25 mg chlortalidone, half a tablet once a day, he receives 12.5 mg intramural chlortalidone, one tablet once a day. Then the nursing does not have to break tablets in this case. Here there is a risk that the patient will use the 25 mg again at home, but then a whole tablet at a time in stead of half a tablet. By means of an explanation in the medication agreement (Additional information) of the last chlortalidone 25 mg, it can be indicated whether this has been a intended increase.

Valuesets

MedicationAgreementAdditionalInformationCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.3 Binding:
Conceptname Conceptcode Codesystem name Codesystem OID Description
Bewust hoge dosering 1 Voorlopige G-std thesaurus 2050 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050 Bewust hoge dosering
Bewust lage dosering 2 Voorlopige G-std thesaurus 2050 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050 Bewust lage dosering
Bewust afwijkende toedieningsweg 3 Voorlopige G-std thesaurus 2050 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050 Bewust afwijkende toedieningsweg
Medische noodzaak 4 Voorlopige G-std thesaurus 2050 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050 Medische noodzaak
Profylaxe 5 Voorlopige G-std thesaurus 2050 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050 Profylaxe
Wijziging in GDS per direct 6 Voorlopige G-std thesaurus 2050 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050 Wijziging in GDS per direct
Wijziging in GDS per rolwissel 7 Voorlopige G-std thesaurus 2050 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.2050 Wijziging in GDS per rolwissel

MedicationAgreementReasonCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2 Binding:
Conceptname Conceptcode Codesystem name Codesystem OID Description
Medication commenced (finding) 266709005 SNOMED CT 2.16.840.1.113883.6.96 Starten medicamenteuze behandeling
Administration of drug or medicament contraindicated (situation) 438833006 SNOMED CT 2.16.840.1.113883.6.96 Contra-indicatie
Drug interaction (disorder) 79899007 SNOMED CT 2.16.840.1.113883.6.96 Interactie
Hypersensitivity condition (disorder) 473010000 SNOMED CT 2.16.840.1.113883.6.96 Overgevoeligheid
Geen of onvoldoende effect 5 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Geen of onvoldoende effect
Te sterk effect 6 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Te sterk effect
(Mogelijke) bijwerking 7 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 (Mogelijke) bijwerking
Toedieningsweg voldoet niet 8 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Toedieningsweg voldoet niet
Indicatie vervallen 9 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Indicatie vervallen
Beleidswijziging 10 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Beleidswijziging
Admission to establishment (procedure) 305335007 SNOMED CT 2.16.840.1.113883.6.96 Opname
Wens patiënt 12 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Wens patiënt
Volgens afspraak 13 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Volgens afspraak
Hervatten beleid vorige voorschrijver 14 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Hervatten beleid vorige voorschrijver
Geplande procedure 15 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Procedure waaronder ingreep, interferentie met gepland labonderzoek, etc.
Overig OTH NullFlavour 2.16.840.1.113883.5.1008 Overig

MedicationAgreementStopTypeCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.1 Binding:
Conceptname Conceptcode Codesystem name Codesystem OID Description
Tijdelijk 1 StopType 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie).
Definitief 2 StopType 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 Het staken van een bestaande medicamenteuze behandeling.

This information model in other releases

Information model references

This information model refers to

This information model is used in

Technical specifications in HL7v3 CDA and HL7 FHIR

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

  • HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment Artdecor.jpg
  • HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR Fhir.png

Downloads

This information model is also available as pdf file PDF.png or as spreadsheet Xlsx.png

About this information

The information in this wikipage is based on Release 2017
Conditions for use are located on the mainpage List2.png
This page is generated on 19/12/2018 18:32:32 with ZibExtraction v. 3.0.6927.32850

Back 16.png Back to HCIM list
Overgenomen van "https://zibs.test-nictiz.nl/index.php?title=MedicationAgreement-v1.0.1(2017EN)&oldid=14417"